Atorvastatin Expert Views

Dr. Bruce Patterson explains that atorvastatin, commonly known as Lipitor, plays a role in reducing inflammation in blood vessels, which is a key factor in the development of atherosclerosis and heart attacks. He highlights that cholesterol contributes to inflammation in blood vessels, creating conditions for atherosclerotic plaques to form. Statins, including atorvastatin, not only reduce this inflammation but also inhibit a pathway involving fractalkine receptors, which are linked to immune cells binding to blood vessels. This mechanism is part of a broader treatment protocol for Long Covid, which aims to address underlying inflammatory processes.

Dr. Dominique Salmon discusses the use of atorvastatin (Lipitor) in treating Long COVID. She explains that a small study involving 18 patients showed some improvement in vascular markers and symptoms like autonomic, respiratory, and cardiac issues after 6 to 12 weeks of treatment. Additionally, she mentions her personal experience with a combination therapy including atorvastatin, which showed promising results in patients with severe digestive symptoms. However, some patients experienced relapses after stopping the treatment, indicating the need for further research and randomized trials.

Joachim Gerlach, chairman of Vedicinals, discusses the use of pharmaceuticals like statins in treating Long Covid. He emphasizes the importance of combining pharmaceuticals with nutraceuticals, such as Vedicinals9, for better results. Gerlach highlights the challenges in conducting clinical trials for nutraceuticals, including funding and ethical approvals. He notes that while individual responses vary, significant improvements have been observed in symptoms like breathlessness and fatigue. For example, clinical trials showed a 75% improvement in lung x-ray findings after 12 days, particularly addressing issues like ground glass opacity.